| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments for taxes related to net settlement of equity awards | 40 | 34 |
| Net cash provided by (used in) financing activities | -437 | -431 |
| Net decrease in cash and cash equivalents | -40,726 | -30,839 |
| Cash and cash equivalents at beginning of period | 49,046 | - |
| Cash and cash equivalents at end of period | 8,320 | - |
BioAtla, Inc. (BCAB)
BioAtla, Inc. (BCAB)